Taipei, Taiwan

Yen-Yen Liu

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yen-Yen Liu. Retrieved from https://idiyas.com/inventor/yen-yen-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yen-Yen Liu: Innovator in Recombinant Baculovirus Technology

Introduction

Yen-Yen Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant baculoviruses and virus-like particles. His innovative work has the potential to impact various applications in medicine and research.

Latest Patents

Yen-Yen Liu holds a patent for a "Recombinant baculovirus and virus-like particle." This patent encompasses recombinant baculoviruses, virus-like particles, and polypeptides that contain a protein sequence of a heterologous virus. It also includes related compositions and methods for preparation, screening, delivery, detection, and treatment.

Career Highlights

Yen-Yen Liu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to explore innovative solutions in biotechnology and contribute to the advancement of scientific knowledge.

Collaborations

Yen-Yen Liu collaborates with Yu-Chan Chao, a fellow researcher. Their partnership exemplifies the collaborative spirit of scientific research, where diverse expertise can lead to groundbreaking discoveries.

Conclusion

Yen-Yen Liu's contributions to recombinant baculovirus technology highlight his role as an influential inventor in the field of biotechnology. His work continues to pave the way for advancements that could benefit various sectors, including medicine and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…